001     169201
005     20240826165948.0
024 7 _ |a 10.3389/fpsyg.2022.957308
|2 doi
024 7 _ |a pmid:36571008
|2 pmid
024 7 _ |a pmc:PMC9773841
|2 pmc
024 7 _ |a altmetric:139938797
|2 altmetric
037 _ _ |a DZNE-2023-00080
041 _ _ |a English
082 _ _ |a 150
100 1 _ |a Kleineidam, Luca
|0 P:(DE-2719)2812139
|b 0
|e First author
245 _ _ |a Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve.
260 _ _ |a Lausanne
|c 2022
|b Frontiers Research Foundation
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1711380635_22710
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Several lifestyle factors promote protection against Alzheimer's disease (AD) throughout a person's lifespan. Although such protective effects have been described for occupational cognitive requirements (OCR) in midlife, it is currently unknown whether they are conveyed by brain maintenance (BM), brain reserve (BR), or cognitive reserve (CR) or a combination of them.We systematically derived hypotheses for these resilience concepts and tested them in the population-based AgeCoDe cohort and memory clinic-based AD high-risk DELCODE study. The OCR score (OCRS) was measured using job activities based on the O*NET occupational classification system. Four sets of analyses were conducted: (1) the interaction of OCR and APOE-ε4 with regard to cognitive decline (N = 2,369, AgeCoDe), (2) association with differentially shaped retrospective trajectories before the onset of dementia of the Alzheimer's type (DAT; N = 474, AgeCoDe), (3) cross-sectional interaction of the OCR and cerebrospinal fluid (CSF) AD biomarkers and brain structural measures regarding memory function (N = 873, DELCODE), and (4) cross-sectional and longitudinal association of OCR with CSF AD biomarkers and brain structural measures (N = 873, DELCODE).Regarding (1), higher OCRS was associated with a reduced association of APOE-ε4 with cognitive decline (mean follow-up = 6.03 years), consistent with CR and BR. Regarding (2), high OCRS was associated with a later onset but subsequently stronger cognitive decline in individuals converting to DAT, consistent with CR. Regarding (3), higher OCRS was associated with a weaker association of the CSF Aβ42/40 ratio and hippocampal volume with memory function, consistent with CR. Regarding (4), OCR was not associated with the levels or changes in CSF AD biomarkers (mean follow-up = 2.61 years). We found a cross-sectional, age-independent association of OCRS with some MRI markers, but no association with 1-year-change. OCR was not associated with the intracranial volume. These results are not completely consistent with those of BR or BM.Our results support the link between OCR and CR. Promoting and seeking complex and stimulating work conditions in midlife could therefore contribute to increased resistance to pathologies in old age and might complement prevention measures aimed at reducing pathology.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 1
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 2
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Alzheimer's disease
|2 Other
650 _ 7 |a brain maintenance
|2 Other
650 _ 7 |a brain reserve
|2 Other
650 _ 7 |a cognitive reserve
|2 Other
650 _ 7 |a mid-life cognitive demands
|2 Other
650 _ 7 |a occupation
|2 Other
693 _ _ |0 EXP:(DE-2719)DELCODE-20140101
|5 EXP:(DE-2719)DELCODE-20140101
|e Longitudinal Cognitive Impairment and Dementia Study
|x 0
700 1 _ |a Wolfsgruber, Steffen
|0 P:(DE-2719)2810544
|b 1
700 1 _ |a Weyrauch, Anne Sophie
|0 P:(DE-2719)9002221
|b 2
|u dzne
700 1 _ |a Zulka, Linn E
|b 3
700 1 _ |a Forstmeier, Simon
|b 4
700 1 _ |a Roeske, Sandra
|0 P:(DE-2719)2810395
|b 5
700 1 _ |a van den Bussche, Hendrik
|b 6
700 1 _ |a Kaduszkiewicz, Hanna
|b 7
700 1 _ |a Wiese, Birgitt
|b 8
700 1 _ |a Weyerer, Siegfried
|b 9
700 1 _ |a Werle, Jochen
|b 10
700 1 _ |a Fuchs, Angela
|b 11
700 1 _ |a Pentzek, Michael
|b 12
700 1 _ |a Brettschneider, Christian
|b 13
700 1 _ |a König, Hans-Helmut
|b 14
700 1 _ |a Weeg, Dagmar
|b 15
700 1 _ |a Bickel, Horst
|b 16
700 1 _ |a Luppa, Melanie
|b 17
700 1 _ |a Rodriguez, Francisca S
|0 P:(DE-2719)9000725
|b 18
700 1 _ |a Freiesleben, Silka Dawn
|0 P:(DE-2719)2812392
|b 19
700 1 _ |a Erdogan, Selin
|0 P:(DE-2719)9001856
|b 20
700 1 _ |a Unterfeld, Chantal
|0 P:(DE-2719)9001894
|b 21
700 1 _ |a Peters, Oliver
|0 P:(DE-2719)2811024
|b 22
700 1 _ |a Spruth, Eike J
|0 P:(DE-2719)2812446
|b 23
700 1 _ |a Altenstein, Slawek
|0 P:(DE-2719)2811720
|b 24
700 1 _ |a Lohse, Andrea
|0 P:(DE-2719)2811189
|b 25
|u dzne
700 1 _ |a Priller, Josef
|0 P:(DE-2719)2811122
|b 26
700 1 _ |a Fliessbach, Klaus
|0 P:(DE-2719)2811326
|b 27
700 1 _ |a Kobeleva, Xenia
|0 P:(DE-2719)9001475
|b 28
700 1 _ |a Schneider, Anja
|0 P:(DE-2719)2812035
|b 29
700 1 _ |a Bartels, Claudia
|0 P:(DE-2719)9000444
|b 30
|u dzne
700 1 _ |a Schott, Björn H
|0 P:(DE-2719)2814326
|b 31
700 1 _ |a Wiltfang, Jens
|0 P:(DE-2719)2811317
|b 32
700 1 _ |a Maier, Franziska
|b 33
700 1 _ |a Glanz, Wenzel
|0 P:(DE-2719)2811614
|b 34
700 1 _ |a Incesoy, Enise I
|0 P:(DE-2719)9001517
|b 35
700 1 _ |a Butryn, Michaela
|0 P:(DE-2719)9001011
|b 36
700 1 _ |a Düzel, Emrah
|0 P:(DE-2719)2000005
|b 37
700 1 _ |a Bürger, Katharina
|0 P:(DE-2719)2811351
|b 38
700 1 _ |a Janowitz, Daniel
|0 P:(DE-2719)9002557
|b 39
|u dzne
700 1 _ |a Ewers, Michael
|0 P:(DE-2719)9000543
|b 40
700 1 _ |a Rauchmann, Boris Stephan
|0 P:(DE-2719)9001808
|b 41
|u dzne
700 1 _ |a Perneczky, Robert
|0 P:(DE-2719)2812234
|b 42
700 1 _ |a Kilimann, Ingo
|0 P:(DE-2719)2810394
|b 43
700 1 _ |a Görß, Doreen
|0 P:(DE-2719)2812583
|b 44
|u dzne
700 1 _ |a Teipel, Stefan
|0 P:(DE-2719)2000026
|b 45
700 1 _ |a Laske, Christoph
|0 P:(DE-2719)2000055
|b 46
700 1 _ |a Munk, Matthias H J
|0 P:(DE-2719)9001516
|b 47
700 1 _ |a Spottke, Annika
|0 P:(DE-2719)2811324
|b 48
700 1 _ |a Roy, Nina
|0 P:(DE-2719)2812341
|b 49
700 1 _ |a Brosseron, Frederic
|0 P:(DE-2719)2810593
|b 50
700 1 _ |a Heneka, Michael T
|0 P:(DE-2719)2000008
|b 51
700 1 _ |a Ramirez, Alfredo
|0 P:(DE-2719)2812825
|b 52
700 1 _ |a Yakupov, Renat
|0 P:(DE-2719)2812398
|b 53
700 1 _ |a Scherer, Martin
|b 54
700 1 _ |a Maier, Wolfgang
|0 P:(DE-2719)2000015
|b 55
|u dzne
700 1 _ |a Jessen, Frank
|0 P:(DE-2719)2000032
|b 56
700 1 _ |a Riedel-Heller, Steffi G
|b 57
700 1 _ |a Wagner, Michael
|0 P:(DE-2719)2000057
|b 58
|e Last author
773 _ _ |a 10.3389/fpsyg.2022.957308
|g Vol. 13, p. 957308
|0 PERI:(DE-600)2563826-9
|p 957308
|t Frontiers in psychology
|v 13
|y 2022
|x 1664-1078
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/169201/files/DZNE-2023-00080.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/169201/files/DZNE-2023-00080.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:169201
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2812139
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810544
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 2
|6 P:(DE-2719)9002221
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2810395
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 18
|6 P:(DE-2719)9000725
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 19
|6 P:(DE-2719)2812392
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 20
|6 P:(DE-2719)9001856
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)9001894
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 22
|6 P:(DE-2719)2811024
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 23
|6 P:(DE-2719)2812446
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 24
|6 P:(DE-2719)2811720
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 25
|6 P:(DE-2719)2811189
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 26
|6 P:(DE-2719)2811122
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 27
|6 P:(DE-2719)2811326
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 28
|6 P:(DE-2719)9001475
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 29
|6 P:(DE-2719)2812035
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 30
|6 P:(DE-2719)9000444
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 31
|6 P:(DE-2719)2814326
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 32
|6 P:(DE-2719)2811317
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 34
|6 P:(DE-2719)2811614
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 35
|6 P:(DE-2719)9001517
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 36
|6 P:(DE-2719)9001011
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 37
|6 P:(DE-2719)2000005
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 38
|6 P:(DE-2719)2811351
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 39
|6 P:(DE-2719)9002557
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 40
|6 P:(DE-2719)9000543
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 41
|6 P:(DE-2719)9001808
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 42
|6 P:(DE-2719)2812234
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 43
|6 P:(DE-2719)2810394
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 44
|6 P:(DE-2719)2812583
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 45
|6 P:(DE-2719)2000026
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 46
|6 P:(DE-2719)2000055
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 47
|6 P:(DE-2719)9001516
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 48
|6 P:(DE-2719)2811324
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 49
|6 P:(DE-2719)2812341
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 50
|6 P:(DE-2719)2810593
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 51
|6 P:(DE-2719)2000008
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 52
|6 P:(DE-2719)2812825
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 53
|6 P:(DE-2719)2812398
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 55
|6 P:(DE-2719)2000015
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 56
|6 P:(DE-2719)2000032
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 58
|6 P:(DE-2719)2000057
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 1
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 2
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-29
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-05-12T11:55:44Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
|d 2022-11-29
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT PSYCHOL : 2021
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1180
|2 StatID
|b Current Contents - Social and Behavioral Sciences
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-05-12T11:55:44Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-05-12T11:55:44Z
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2022-11-29
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-29
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-05-12T11:55:44Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-29
920 1 _ |0 I:(DE-2719)1011201
|k AG Wagner
|l Neuropsychology
|x 0
920 1 _ |0 I:(DE-2719)1510900
|k AG Rodriguez
|l Psychosocial Epidemiology and Public Health
|x 1
920 1 _ |0 I:(DE-2719)1811005
|k AG Endres
|l Interdisciplinary Dementia Research
|x 2
920 1 _ |0 I:(DE-2719)1810002
|k AG Dirnagl
|l Vascular Pathology
|x 3
920 1 _ |0 I:(DE-2719)5000007
|k AG Priller
|l Translational Neuropsychiatry
|x 4
920 1 _ |0 I:(DE-2719)1011101
|k Patient Studies Bonn
|l Patient Studies Bonn
|x 5
920 1 _ |0 I:(DE-2719)1011001
|k AG Klockgether
|l Patient Studies
|x 6
920 1 _ |0 I:(DE-2719)1011305
|k AG Schneider
|l Translational Dementia Research (Bonn)
|x 7
920 1 _ |0 I:(DE-2719)1410002
|k AG Fischer
|l Epigenetics and Systems Medicine in Neurodegenerative Diseases
|x 8
920 1 _ |0 I:(DE-2719)1410006
|k AG Wiltfang
|l Molecular biomarkers for predictive diagnostics of neurodegenerative diseases
|x 9
920 1 _ |0 I:(DE-2719)1340013
|k KAP
|l Cooperation Unit for Applied Prevention Research (KAP)
|x 10
920 1 _ |0 I:(DE-2719)5000006
|k AG Düzel
|l Clinical Neurophysiology and Memory
|x 11
920 1 _ |0 I:(DE-2719)5000022
|k AG Dichgans
|l Vascular Cognitive Impairment & Post-Stroke Dementia
|x 12
920 1 _ |0 I:(DE-2719)1510100
|k AG Teipel
|l Clinical Dementia Research (Rostock /Greifswald)
|x 13
920 1 _ |0 I:(DE-2719)1011301
|k Biomarker
|l Interventional Trials and Biomarkers in Neurodegenerative Diseases
|x 14
920 1 _ |0 I:(DE-2719)1011102
|k AG Jessen
|l Clinical Alzheimer’s Disease Research
|x 15
920 1 _ |0 I:(DE-2719)1011401
|k Clinical Research Platform (CRP)
|l Clinical Research Platform (CRP)
|x 16
920 1 _ |0 I:(DE-2719)1110008
|k AG Simons
|l Molecular Neurobiology
|x 17
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 18
920 1 _ |0 I:(DE-2719)5000034
|k Delcode
|l Delcode
|x 19
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1011201
980 _ _ |a I:(DE-2719)1510900
980 _ _ |a I:(DE-2719)1811005
980 _ _ |a I:(DE-2719)1810002
980 _ _ |a I:(DE-2719)5000007
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a I:(DE-2719)1011001
980 _ _ |a I:(DE-2719)1011305
980 _ _ |a I:(DE-2719)1410002
980 _ _ |a I:(DE-2719)1410006
980 _ _ |a I:(DE-2719)1340013
980 _ _ |a I:(DE-2719)5000006
980 _ _ |a I:(DE-2719)5000022
980 _ _ |a I:(DE-2719)1510100
980 _ _ |a I:(DE-2719)1011301
980 _ _ |a I:(DE-2719)1011102
980 _ _ |a I:(DE-2719)1011401
980 _ _ |a I:(DE-2719)1110008
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)5000034
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21